Neuroprotective strategies for HIV-1-associated neurologic disease.
Gelbard
H A
HA
Department of Neurobiology, University of Rochester, NY 14642-8677, USA. hgelbard@neurology.rochester.edu
D015526:AIDS Dementia Complex / Q000188:drug therapy / Q000378:metabolism*; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D015497:HIV-1 / Q000378:metabolism; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D017628:Microglia / Q000187:drug effects / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000187:drug effects / Q000378:metabolism*; D018091:Receptors, AMPA / Q000187:drug effects / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D018696:Neuroprotective Agents; D010972:Platelet Activating Factor; D018091:Receptors, AMPA; D014409:Tumor Necrosis Factor-alpha